
Please try another search
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada. It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
Name | Age | Since | Title |
---|---|---|---|
Scott Rodeo | - | - | Member of Clinical Advisory Board |
Pierre Laurin | 63 | 2019 | Interim CEO & Chairman |
Jacques Toueg | - | 2018 | Member of Clinical Advisory Board |
Jack Farr | - | - | Member of Clinical Advisory Board |
Martyn Snow | - | - | Member of Clinical Advisory Board |
Steven Saviuk | 65 | 2015 | Director |
Patrick T. O'Donnell | 59 | 2021 | Independent Director |
Howard P. Walthall | 52 | 2021 | Independent Director |
Timothy M. Cunningham | 61 | 2021 | Independent Director |
Brent Henry-Barry Norton | 64 | 2016 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review